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Abstract
Methicillin-resistant Staphylococcus aureus has emerged as a serious threat to public health, 
causing both hospital and community-associated infections. The gold standard for MRSA detection is 
the amplification of the mecA gene that codes for the production of the altered penicillin-binding 
protein (PBP2a) responsible for classical methicillin resistance. This work determined the nature of 
methicillin-resistance observed in staphylococcal isolates. Staphylococcus aureus isolates with 
phenotypic resistance to methicillin (oxacillin) were tested for the carriage of the mecA gene by 
multiplex PCR to detect and type the SCCmec. The isolates were tested for the production of the 
altered PBP2a by latex agglutination test and β-lactamase production/hyper production by microplate 
Nitrocefin assay. None of the isolates hybridized with any of the 16 sets of primers representing the 
five major SCCmec types, nor contained the mecA gene; and none was positive for the gene product 
PBP2a determined by the MRSA screen latex agglutination test. Majority of the isolates 72.2 % 
(26/36) tested positive for β-lactamase production while 11/26 (42.3%) were β-lactamase hyper 
producers. The MRSA phenotype observed in the isolates was not the classical mecA-mediated 
resistance, but most probably due to hyper-production of β-lactamase. Reports of loss of the mecA 
gene (believed to be stable) during storage and the fact that all PCR detection of mecA gene reported 
in Nigeria were done outside the country calls for attention on building local capacity for prospective 
molecular screening for MRSA in clinical and environmental isolates to adequately document their
prevalence and monitor the increase. Appropriate guidelines should also be drawn up for the proper 
screening and reporting of MRSA isolates with the establishment of regional Reference Laboratories. 
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Introduction
Staphylococcus aureus is a major pathogen both within hospitals and in the community 
(Stapleton and Taylor, 2002). In the pre-antibiotic era, the rate of mortality from invasive 
Staphylococcus aureus disease was high and the introduction of penicillin had a dramatic impact on 
treatment (Grubb, 1998). The semi-synthetic penicillin, methicillin was introduced in 1959 to overcome 
the problems that arose from the increasing prevalence of penicillinase-producing isolates of 
Staphylococcus aureus resistant to penicillin G and penicillin V. (Enright et al., 2002). Today, the 
whole world contends with methicillin-resistant Staphylococcus aureus (MRSA) as a major clinical 
problem (Benner, and Kaysser, 1968; Lowy, 1998) with many strains resistant to most other classes of 
antimicrobial agents (Panlilio et al., 1992; Speller et al., 1997).
Afr. J. Infect. Diseases
www.africanethnomedicines.net
Olayinka et al.,  Afr. J. Infect. Dis. (2009) 3(2): 49 - 56 - 50 -
Strains of Staphylococcus aureus resistant to methicillin have been isolated as a frequent 
pathogen in hospital settings in patients with well-described risk factors (Lowy, 1998). The acronym 
MRSA is somewhat misleading because the semi-synthetic -lactam, methicillin is no longer used to 
treat S. aureus infections; MRSA has come to traditionally represent S. aureus strains that are 
resistant to multiple antibiotics and associated with nosocomial infections. (Hiramatsu et al., 2001, 
Chambers, 1997, Foster, 2004).
The mechanism of methicillin resistance is the possession of an altered penicillin binding 
protein (PBP2a), that is encoded by the mecA gene carried on a mobile DNA element, the 
Staphylococcal cassette chromosome mec (SCCmec) (Lowy, 2003; Katayama et al., 2000). The mecA 
gene-product, PBP2a is an inducible, 76-78 kDa penicillin binding protein which in MRSA strains 
substitutes the other PBPs and because of its low affinity for all β-lactam antibiotics enables the 
organism to survive exposure to high concentrations of this class of antimicrobial agents (Chambers, 
1997; Chambers, 2001; Lowy, 2003).
Detection of methicillin-resistance is complicated by the fact that mecA expression can either 
be heterogeneous or homogenous (Chambers, 1997). MRSA strains expressing heterogeneous
resistance characterized by a predominantly low-level resistant population co-existing with a small 
proportion of highly resistant cells, are often misclassified as methicillin-susceptible Staphylococcus 
aureus (MSSA) by most conventional culture methods and thus represent a hidden reservoir in 
hospitals (Foster, 2004). It has been observed that the heterogeneous expression of methicillin 
resistance and the slow growth of the resistant bacteria can make detection difficult. Detection using 
methicillin and oxacillin is therefore aided by carrying out the test at neutral pH; reduced incubation 
temperature of 330C–350C; supplementing the agar/broth with 2%-4% NaCl and 24 hr incubation time.
Methodology
Collection of isolates
Suspected Staphylococcal isolates were collected from clinical specimens submitted to the 
diagnostic Medical Microbiology laboratory of the Ahmadu Bello University Teaching Hospital, Zaria 
over a cumulative period of 18 months.
Identification of S. aureus isolates.
Isolates were inoculated unto Mannitol Salt agar plates and incubated at 370C for 24 to 48hrs. 
Plates were examined for growth of colonies with the characteristic golden colouration. The isolates 
were characterized by their Gram stain characteristics, catalase test, slide and tube coagulase tests to 
confirm the S. aureus isolates (Baird, 1996).
Determination of methicillin (oxacillin) susceptibility. 
Nutrient agar medium containing 5% of sodium chloride (Cookson and Phillips, 1990) was 
prepared, distributed in 20ml aliquots into bottles and sterilized at I210C for I5 mins. Overnight cultures 
of the confirmed S. aureus isolates were emulsified in 3ml of Phosphate buffered solution (PBS) and 
turbidity adjusted to 0.5 McFarland were inoculated unto the NA plates by swabbing. Oxacillin discs, 
1µg (Oxoid, UK) were placed on the dried agar plates and incubated for 18 hrs at 350C. The diameter 
of the zones of inhibition were measured and isolates classified as susceptible, intermediate and 
resistant based on CLIS interpretative chart of zone sizes (Cheesbrough, 2002; CLSI, 2006). Isolates 
with growth within the zone of growth inhibition were regarded as hetero-resistant strains.
Molecular detection of methicillin-resistance gene
A total of 36 isolates of Staphylococcus aureus with phenotypic resistance to methicillin/
(oxacillin1µg) and showing multiple antibiotic resistance (resistance to three antibiotic classes, apart 
from β-lactams) determined by DAD were selected for analysis and molecular detection of mecA
gene. The isolates were part of those from specimens submitted to the diagnostic Medical 
Microbiology laboratory of Ahmadu Bello University Teaching Hospital, Shika-Zaria, Nigeria.
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Multiplex PCR for detecting mecA gene and SCCmec type element assignment
             Chromosomal DNA was extracted from the isolates by a rapid boiling extraction method 
(Caddick et al., 2005). Staphylococcal Cassette Chromosome mec (SCCmec) element assignment 
was determined for all MRSA isolates using primers and cycle conditions previously described, Table 
1 (Oliveira and de Lencastre, 2002).  Multiplex PCR was performed using Gene Amp PCR system 
9700 (Applied Biosystems, UK) in a 25µl reaction volume comprising of 17.7µl SDW, 2.5µl of 10x 
primer mix (Table3.1) 0.2µl of 25mM dNTPs (Promega, UK), 0.1µl of 1.25 units/µl Taq DNA 
polymerase (Promega, UK) and 2µl template DNA.  SCCmec band pattern validation was carried out 
using the positive control strains COL, PER34, N315, ANS46, HU25 and MW2 representing SCCmec
element types I, Ia, II, III, IIIa and IV respectively.  A 2% agarose gel containing 1µg/ml of ethidium 
bromide was used to separate amplified fragments.  Electrophoresis was performed in 1x TAE (40mM 
Tris, 1mM EDTA and 0.1% (v/v) glacial acetic acid) buffer at 100 volts for 1 hr.
Table1: Primers and stock concentrations used in SCCmec multiplex PCR (Oliveira and de Lencastre, 
2002).






































































Detection of PBP2a by MRSA Screen Latex agglutination test
Detection of PBP2a was carried out using a slide agglutination kit (MRSA-Screen test Denka 
Seiken Co Ltd. Japan) and performed according to the manufacturer’s instructions.  EMRSA-15 was 
used as a mec-positive control strain and Oxford Staphylococcus aureus NCTC 8325 as a mec-
negative control strain.  The sample colonies were taken from a fresh BHI agar plate and re-
suspended in 4 drops (approximately 200µl) of extraction reagent no.1 (0.1M NaOH) and boiled for 
3 min.  Following boiling 1 drop (approximately 50 µl) of extraction reagent no.2 (0.5M KH2PO4) was 
aliquoted into the suspension mix and vortexed for 30 seconds.  The sample was then centrifuged at 
1,500 × g for 5 min at room temperature.  A 50 µl sample of the test isolate supernatant, the positive-
control and the negative-control was placed on the provided slides.  One drop (approximately 25 µl) of 
anti-PBP2a monoclonal antibody-sensitized latex was added to each sample for the positive control 
and one drop (approximately 25 µl) of negative-control latex was added to each sample for a negative 
control.  The slides were rotated by hand for 3 mins and characteristic agglutination indicated a 
positive result for PBP2a production.
Determination of β-lactamase hyper production by Microplate Nitrocefin assay
The 1mg lyophilized Nitrocefin powder (Oxoid, UK) was reconstituted in 1.9ml of 0.1M 
phosphate buffer, pH7 supplied by the manufacturer. The reconstituted Nitrocefin was further diluted 
1in 10 with PBS to give 50µg/ml solution. The disrupted cell preparations were used immediately by 
dispensing 50µL of preparation into separate wells of a 96 well plate. 50µL of diluted Nitrocefin 
solution was added into each of the wells and incubated at 370C for 10mins. In the presence of β-
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lactamase, the chromogenic nitrocefin substrate changes colour from yellow to pink/red.  A positive 
control was set up with MRSA-15.
Results
The staphylococcal isolates from clinical and environmental samples were made up of 254 
(75.8%) Staphylococcus aureus, out of which a total of 139(54.7%) were resistant to methicillin as 
determined by DAD method on Nutrient agar medium containing 5% of sodium chloride. Twenty-seven 
isolates, representing 8.0% yielded hetero-resistant strains that were able to grow within the zone of 
growth inhibition. The distribution of the MRSA isolates by source is shown in Figure 1. Most of the 
isolates were from wound (42%), urine (15%) and urethral swab (11%).
Figure1: Distribution of MRSA isolates by source.
Multiplex PCR for detecting mecA gene and SCCmec type element assignment
All the isolates were mecA-negative since there was no amplification of target DNA primers in 
the PCR run (Plate 1).
MW P N S16 M1 S13 M45 M9 S10 M21 M14 S6
MW M37 S17 S1 S29 S11 M15 N P SDW
Band show presence of mecA gene
Plate 1: Multiplex PCR on isolates for SCCmec type assignment. P=Positive control, N=Negative 
control, MW=Molecular weight marker, SDW=Sterile distilled water.
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Detection of PBP2a by MRSA Screen Latex agglutination test
The presence of the mecA gene product PBP2a was determined in isolates by the MRSA 
Screen Latex agglutination test kit (Denka Seiken Co Ltd. Japan).
None of the isolates were PBP2a-positive, since there was no characteristic agglutination except in the 
positive control, EMRSA-15 (Plate 2).
Detection of β-lactamase hyper-production.
             Hyper-production of β-lactamase in isolates was detected by the intensity of the colour 
change in the Microplate Nitrocefin assay compared with the positive control (MRSA-15). A total of 26 
out of the 36(72.2%) isolates tested produced β-lactamase giving the positive colour change from 
yellow to pink within the 10mins of incubation time. Intense colour change greater than control was 
observed in 11/36 (30.6%) of isolates.
TESTCONTROL
EMRSA-15
Plate 2: MRSA Screen Latex agglutination test result shows agglutination in the 
mecA-positive control (MRSA-15).
Discussion
The distribution of MRSA by source in this study is consistent with various studies that 
identified wounds (surgical/burns), urine and pus/abscess as important sources of MRSA isolation
(Daxboeck et al., 2004; Orrett and Land, 2006). 
Determination of methicillin (oxacillin) susceptibility of isolates by the DAD method revealed a 
worrisome 54.7% resistance rate. The rate of MRSA in this study is higher than those reported by 
other investigators in the country. In a survey on the prevalence of MRSA in eight African countries 
and Malta, Kesah et al. (2003) reported the highest rate of 29.6% for Lagos University Teaching 
Hospital, Nigeria. Taiwo et al. (2004) reported a rate of 34.7% for Ilorin; Olonitola et al (2007) reported 
a rate of 33.3% from a Federal Medical Centre and Ikeh (2003) had a rate of 43% for Jos.
Onanuga et al. (2006) reported a higher rate of 71.1% from urine of healthy women while Ikeh and 
Yakeu (2006) reported an alarming 92.6% MRSA out of the S. aureus isolated from bacteria flora on 
the hands of nursing service workers. 
A common factor in all these studies is the method of detecting MRSA; the DAD susceptibility 
test against 5µg methicillin or 1µg oxacillin, which is generally regarded as less specific in detecting 
classical methicillin resistance mediated by mecA gene that codes for the production of an additional 
penicillin binding protein, PBP2a or PBP2’ which confers resistance to all β-lactam antibiotics (Brown 
et al., 2005).
Methicillin resistance isolates with alterations to the existing PBPs have been described 
(Chambers et al, 1989; Montanari et al., 1990; de Lencastre et al., 1991) and they are termed 
moderately resistant S. aureus (MODSA). Under some test conditions it has also been reported that 
isolates which produce large amounts of penicilinase (β-lacatmase hyper producers) show low level 
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resistance to oxacillin and have been referred to as Borderline oxacillin-resistant S. aureus (BORSA) 
(Chambers et al., 1989). The clinical importance of MODSA and BORSA strains had been doubtful, 
since there had been no treatment failures with penicillinase resistant penicillins (Thauvin-Eliopoulos 
et al., 1990; Hirano and Bayer, 1991).
Although the disc diffusion method remains the most widely used in routine clinical 
laboratories, it has been suggested that oxacillin (methicillin) be replaced by cefoxitin, a more potent 
inducer of mecA expression, that is less affected by test conditions and hyperproduction of 
penicillinase (Brown et al., 2005). With the cefoxitin disc becoming increasingly available, it is hoped 
that this will eventually replace oxacillin (methicillin) in clinical laboratories and research work on 
MRSA prevalence.
The gold standard for detection of MRSA is the polymerase chain reaction, PCR that detects 
the mecA gene (Berger Bächi and Roher, 2002) or alternatively detecting the mecA gene product 
PBP2a by latex agglutination tests.
All the 36 isolates selected for molecular characterization by the amplification of the genetic 
determinant of methicillin resistance, mecA gene by the multiplex-PCR typing of the SCCmec element 
that carries the gene revealed that none of the isolates carried the mecA gene. 
Most reports of MRSA in Nigeria have been based on the DAD test results (Taiwo et al., 2004; 
Ikeh, 2003; Onanuga et al., 2006; Ikeh and Yakeu, 2006). The reports of molecular detection of MRSA 
have been limited and had different rates for MRSA detected by DAD test and amplification of the 
mecA gene. 
Adesida et al. (2005) reported that of the 276 S. aureus isolates tested, 26/276 (9.4%) 
seemed to be MRSA based on zone of inhibition diameter but only 4/26 (1.4%) carried the mecA gene 
and contained the mecA gene product, PBP2a determined by MRSA-Screen latex agglutination test. 
Shittu et al. (2006) found 3% of isolates resistant to oxacillin but only 3/200 (1.5%) were confirmed to 
be MRSA by PCR detection of the mecA gene. None of the isolates in this study produced the altered 
PBP2a. The question is what then is the nature of the methicillin resistance observed in these and 
other isolates in this study?   Various other mechanisms have been adduced for observed methicillin 
resistance in S. aureus (Chambers, 1997; Brown et al., 2005). Strains of S. aureus with reduced 
susceptibility to penicillinase-resistant-penicillins (PRP) have been categorized as follows;
 ‘Classical’ MRSA which produce the altered, low-affinity PBP2a, encoded by the mecA gene
 The borderline (low-level)-methicillin resistant strains of S. aureus (BORSA) generally 
considered as being due to hyper-production of type-A-β-lactamase. These BORSA strains 
are mecA-negative, PBP2a-negative 
 Strains with modified ‘normal’ PBPs due to altered binding capacity or over-production of 
PBPs. These strains are termed MODSA. 
A total of 26/36 (72%) of isolates tested by the microplate Nitrocefin assay produced β-lactamase 
while 11/36 (30.6%) hyper-produced β-lactamase. The methicillin-resistance observed in the mecA-
negative, PBP2a-negative S. aureus strains in this study may therefore be attributable to the hyper-
production of β-lactamase in only 30.6% of the isolates tested. This can definitely not explain the high 
rate of phenotypic MRSA detected in this study.
The SCCmec element containing the mecA gene was generally believed to be stable after 
incorporation into the strain. However, Griethysen et al. (2005) reported the loss of the mecA gene 
during storage of 36/250 (14.4%) confirmed MRSA strains at -800C with the MicroBank system (Pro-
Lab Diagnostics, Canada). The molecular characterization of isolates in this study as well as the two 
known reports (Adesida et al., 2005; Shittu et al., 2006) were all carried out abroad which would have 
meant collecting the isolates over a period of time, preliminary characterization, storing and sub-
culturing over a considerable length of time before final transportation for molecular characterization. It 
is therefore not impossible given our power situation that some classical mecA-containing isolates 
might have lost the gene on prolonged storage at temperature much higher than -800C.
Conclusion
The phenotypic methicillin-resistance observed in staphylococcal isolates by the DAD test was 
not due to the production of the altered PBP2a encoded by the mecA-gene. The β-lactamase hyper-
production observed in some of the isolates might have been responsible for their ‘masquerading’ as 
MRSA. However, the multiply resistance nature of these MSSA strains and the ability of 
Staphylococcus aureus to take up the mecA-gene, calls for continual surveillance for MRSA and the 
drawing up of guidelines for the prompt, effective and reliable detection of MRSA in resource limited 
setting like ours. MRSA has emerged as an important nosocomial and community-associated
pathogen with constantly changing epidemiology worldwide. There is nothing more international as 
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infection and there are no barriers to a multidrug resistant pathogen carried across borders by man. 
Though classical mecA-mediated MRSA seems not to be a problem yet in our hospitals, now is the 
time to build local capacity in understanding and dealing with this clinically important pathogen with 
worldwide public health importance.
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